Photodynam ic therapy (PDT) can be used as palliative therapy to reduce obstructive symptoms in patients with advanced lung cancer. Herein, we report on the case of a patient with fatal broncho-m ediastinal fistula after PDT. A 57-year-old wom an was diagnosed as non-sm all cell lung cancer (squam ous cell carcinom a, cT4N3). She received PDT on the endobronchial m ass obstructing her right m ain bronchus twice in 48 hours interval. Two weeks later, concurrent chem oradiation therapy (CCRT) with weekly Paclitaxel/Carboplatin was started. During m aintenance chem otherapy, a new nodule in her scalp developed and turned out to be a m etastatic nodule. A broncho-m ediastinal fistula was suspicious on follow-up chest com puted tom ography and a broncoscopy revealed an extensively damaged medial right main bronchial wall. O n the day following bronchoscopy, the patient died of sudden m assive hem optysis. 
Photodynamic therapy (PDT) with radiotherapy can be used as a palliative therapy in late stage non-small cell lung cancer patients with endobronchial obstructive lesions to reduce symptoms. Physicians must consider the potential side effects of PDT. We report a case with fatal broncho-mediastinal fistula after PDT.
CASE REPORT
A 57-year old woman was admitted to our hospital for evaluation of a lung mass. She was a current 30 pack-year smoker and had no other past medical history. Four months prior to hospital admission, the patient began to experience cough, dyspnea, and occasional blood tinged sputum. Therefore, she visited a local clinic and was treated for bronchial asthma.
Despite asthma treatment for 2 months, there was no improvement in symptoms and, she visited another hospital and had a chest computed tomography (CT) scan on which her lung mass was detected. Initial chest CT showed a left mediastinal mass adjacent to the left innominate vein and aorta, the right main bronchus encircling the mass, multiple mediastinal and hilar lymphadenopathies, and a left supraclavicular lymphadenopathy. She was diagnosed with non-small cell lung cancer (squamous cell carcinoma, cT4N3) after needle aspiration biopsy of the left supraclavicular lymph node. A bronchoscopy revealed nearly total obstruction of the right main bronchus due to an endobronchial mass, and tumor infiltration was observed from the carina to the left main bronchus 2 cm from the carina. to be a metastatic lesion by skin biopsy. The patient had been off chemotherapy due to disease progression and the status of disease was reevaluated. The main lung mass remained in a decreased status, but the broncho-mediastinal fistula and left femur shaft metastasis was found to be suspicious (Fig. 1) . The patient was referred to an emergency room for further evaluation and management. On the following day, a bronchoscopy was performed to identify the broncho-mediastinal fistula on previously treated area. On bronchoscopy, the medial right main bronchial wall was extensively damaged and connected to the left main bronchus, and was filled with yellowish necrotic material (Fig. 2) . The right upper lobar bronchus wall looked intact. On the day following bronchoscopy, the patient died of sudden massive hemoptysis.
DISCUSSION
PDT was established as an effective local therapy for the palliative care of obstructing endobronchial lung cancer (1-3). We assume that more severe tissue necrosis could be caused by immediate vascular damage related to PDT itself as well as the synergistic effects of the photosensitizer and ionizing radiation by Paclitaxel based CCRT performed immediately after PDT.
In conclusion, we must carefully consider whether PDT is suitable since severe toxicity is possible when administered together with other therapeutic modalities in patients with advanced lung cancer.
